Hu Jungang, Cao Guang, Xu Liang, Zheng Kanglian, Zhu Xu, Yang Renjie, Wang Xiao, Wang Xiaodong
Department of Radiology, Civil Aviation General Hospital, Beijing, 100123, China.
Department of Interventional Radiology, Peking University Cancer Hospital & Institute, Key Laboratory of Carcinogenesis and Translational Research(Ministry of Education), Beijing, 100142, China.
J Interv Med. 2020 Oct 12;4(1):27-31. doi: 10.1016/j.jimed.2020.10.004. eCollection 2021 Feb.
This study aimed to introduce and evaluate a new embolization technique for the right gastric artery (RGA) during percutaneous implantation of a port-catheter system for hepatic arterial infusion chemotherapy (HAIC).
From January 2013 to January 2017 159 patients with unresectable advanced liver cancer underwent percutaneous implantation of a port-catheter system. In 86 of these patients (56 men; aged 28-88 years; mean: 60.6 ± 12.0 years), in whom the RGA was obvious on arteriography, embolization of RGA was attempted using microcoils to protect the gastric mucosa during HAIC. In the first phase (first three years), antegrade embolization of the RGA using a 2.7 Fr microcatheter was performed in 55 patients. In the second phase (next two years), embolization of the RGA was attempted by combining antegrade embolization and retrograde embolization through the left gastric artery (LGA) in 31 patients. The success rates and the incidence of acute gastroduodenal mucosal toxicity (AGMT) in these two groups were compared.
The total success rate of the RGA embolization was 70.9%. The success rate was 83.9% in 31 patients who underwent combined antegrade and retrograde embolization, which was significantly higher than that of antegrade embolization alone (63.6%) performed in 55 patients ( = 0.047). No complications related to embolization of RGA were documented. The incidence of AGMT was 29.1% (16/55) in patients in the first phase, which was significantly higher than that in the patients in the second phase (9.7%, 3/31) ( = 0.037).
A combination of retrograde embolization via LGA could increase the success rates of RGA embolization and reduce the incidence of AGMT after HAIC.
本研究旨在介绍和评估经皮植入肝动脉灌注化疗(HAIC)的导管系统时,一种用于胃右动脉(RGA)的新栓塞技术。
2013年1月至2017年1月,159例不可切除的晚期肝癌患者接受了经皮导管系统植入术。其中86例患者(56例男性;年龄28 - 88岁;平均:60.6 ± 12.0岁),其RGA在血管造影中显示明显,在HAIC期间尝试使用微线圈栓塞RGA以保护胃黏膜。在第一阶段(前三年),55例患者使用2.7 Fr微导管对RGA进行顺行栓塞。在第二阶段(接下来的两年),31例患者尝试通过联合顺行栓塞和经胃左动脉(LGA)逆行栓塞RGA。比较这两组的成功率和急性胃十二指肠黏膜毒性(AGMT)的发生率。
RGA栓塞的总成功率为70.9%。31例接受顺行和逆行联合栓塞的患者成功率为83.9%,显著高于55例仅接受顺行栓塞患者的成功率(63.6%)(P = 0.047)。未记录到与RGA栓塞相关的并发症。第一阶段患者中AGMT的发生率为29.1%(16/55),显著高于第二阶段患者(9.7%,3/31)(P = 0.037)。
经LGA逆行栓塞联合应用可提高HAIC后RGA栓塞的成功率,并降低AGMT的发生率。